TrialPediatric blood & cancer2011

Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group.

Martin A Champagne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.